Sign In
Buy PRPH
$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
12:10pm, Tuesday, 05'th Jan 2021
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive secur
ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
04:15pm, Tuesday, 08'th Dec 2020
Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities – Aiming For Capacity to Process 50,000 Tests per Day
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
08:30am, Monday, 16'th Nov 2020
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for the
ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
08:30am, Tuesday, 10'th Nov 2020
DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will
